Organizational and activational effects of testosterone on masculinization of female physiological and behavioral stress responses.
The prevalence of affective disorders is two times greater in women than in men. The onset of anxiety and depression occurs at different ages that may correspond to key developmental periods when the brain is more vulnerable to hormonal and exogenous influences. Because stressful life events can precipitate disease onset, the development of greater stress sensitivity in females may contribute to their increased vulnerability. Gonadal hormone exposure in males during early development and again from puberty onward plays a prominent role in sexually dimorphic brain formation, possibly contributing to sex differences in stress responsivity. Therefore, organizational effects of testosterone propionate (TP) administered postnatally and activational effects of TP administered beginning at puberty on adult female physiological and behavioral stress responses were examined in mice. Although the activational effects of TP in females ameliorated the sex difference in the hypothalamic-pituitary-adrenal axis stress response, there was no effect of postnatal TP. Similarly, higher immobile time in intact females in the tail suspension test was blunted by activational TP in the absence of postnatal TP. However, in the marble-burying test of anxiety-like behaviors, organizational and activational TP independently resulted in increased burying behaviors. These results show that TP administration has distinct effects on reducing physiological and behavioral stress responsivity in rodent models and suggest that sex differences in these responses may partially result from the absence of testosterone in females.
Goel
Nirupa
N
University of Pennsylvania, 3800 Spruce Street, Philadelphia, Pennsylvania 19104, USA.
Bale
Tracy L
TL
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D005260:Female; D019417:Hindlimb Suspension; D008297:Male; D051379:Mice; D010052:Ovariectomy; D011897:Random Allocation; D012733:Sex Differentiation / Q000187:drug effects*; D013312:Stress, Physiological / Q000187:drug effects*; D013739:Testosterone / Q000494:pharmacology*; D043343:Testosterone Propionate / Q000494:pharmacology
D013739:Testosterone; D043343:Testosterone Propionate